Ratios Revealed: Decoding ARS Pharmaceuticals Inc (SPRY)’s Financial Health

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.95 million shares were traded. SPRY stock price reached its highest trading level at $13.0955 during the session, while it also had its lowest trading level at $12.53.

Ratios:

Our analysis of SPRY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 32.78 and its Current Ratio is at 32.78. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.

Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 26 ’24 when Thompson Peter A. sold 83,695 shares for $13.00 per share. The transaction valued at 1,088,035 led to the insider holds 0 shares of the business.

ORBIMED ADVISORS LLC sold 83,695 shares of SPRY for $1,088,035 on Aug 26 ’24. The Director now owns 0 shares after completing the transaction at $13.00 per share. On Aug 21 ’24, another insider, Thompson Peter A., who serves as the Director of the company, sold 407,700 shares for $13.56 each. As a result, the insider received 5,526,601 and left with 544,677 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1258301952 and an Enterprise Value of 1039718080. For the stock, the TTM Price-to-Sale (P/S) ratio is 2516.56 while its Price-to-Book (P/B) ratio in mrq is 5.85. Its current Enterprise Value per Revenue stands at 2079.436 whereas that against EBITDA is -18.346.

Stock Price History:

Over the past 52 weeks, SPRY has reached a high of $16.50, while it has fallen to a 52-week low of $2.55. The 50-Day Moving Average of the stock is 19.81%, while the 200-Day Moving Average is calculated to be 55.97%.

Shares Statistics:

SPRY traded an average of 980.42K shares per day over the past three months and 1623030 shares per day over the past ten days. A total of 96.41M shares are outstanding, with a floating share count of 48.63M. Insiders hold about 49.92% of the company’s shares, while institutions hold 38.13% stake in the company. Shares short for SPRY as of 1723680000 were 12065892 with a Short Ratio of 12.31, compared to 1721001600 on 8738917. Therefore, it implies a Short% of Shares Outstanding of 12065892 and a Short% of Float of 23.45.

Most Popular